Donald Wuchterl
Director/Board Member at ABEONA THERAPEUTICS INC.
Net worth: 329 275 $ as of 31/05/2024
Profile
Donald A.
Wuchterl is currently an Independent Director at Abeona Therapeutics, Inc. He previously held the position of Senior VP-Technical Operations & Quality at Astellas Gene Therapies, Inc. from 2016 to 2021.
Prior to that, he served as the Chief Operating Officer & Senior Vice President at Cytovance Biologics, Inc. from 2012 to 2016.
Additionally, he was the Senior VP & Chief Manufacturing Officer at T-Knife Therapeutics, Inc. from 2021 to 2022.
Mr. Wuchterl obtained his undergraduate degree from Colorado Technical University, Inc. and holds an MBA from Fitchburg State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 01/03/2024 | 75,177 ( 0.18% ) | 329 275 $ | 31/05/2024 |
Donald Wuchterl active positions
| Companies | Position | Start |
|---|---|---|
| ABEONA THERAPEUTICS INC. | Director/Board Member | 19/04/2021 |
Former positions of Donald Wuchterl
| Companies | Position | End |
|---|---|---|
| T-Knife Therapeutics, Inc. | Corporate Officer/Principal | 01/08/2022 |
| AUDENTES THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2021 |
Cytovance Biologics, Inc.
 Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | Chief Operating Officer | 01/01/2016 |
Training of Donald Wuchterl
| Fitchburg State University | Masters Business Admin |
| Colorado Technical University, Inc. | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ABEONA THERAPEUTICS INC. | Health Technology |
| Private companies | 3 |
|---|---|
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Astellas Gene Therapies, Inc. is a biotechnology company, which engages in the development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA. | Health Technology |
Cytovance Biologics, Inc.
Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | Health Technology |
| T-Knife Therapeutics, Inc. |
- Stock Market
- Insiders
- Donald Wuchterl
